Research Article
Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India
Table 3
Immunological profile of study subjects.
.
| | | Number | Percentage |
| CD4 count (cells/µL) | 0–50 | 6 | 5% | 51–100 | 14 | 12% | 101–200 | 26 | 22% | 201–300 | 28 | 23% | 301–400 | 32 | 27% | 401–500 | 6 | 5% | >500 | 8 | 7% |
| | | Mean (standard deviation) | 95% confidence interval | value |
| Mean CD4 counts in relation to the presenting complaints (cells/µL) | Single complaint
| 318 (86) | 176 to 389 | 0.0004 | Double complaint
| 272.1 (118) | 202 to 344 | 0.0001 | Three complaints
| 223 (107) | 179 to 268 | 0.0001 | Four complaints
| 136 (94) | 21 to 251 | 0.0045 | Five complaints
| 49 (22) | 21 to 109 | |
| | | Mean (standard deviation) | 95% confidence interval | value |
| Mean CD4 counts in relation to the presence of Candida infection (cells/µL) | Subjects with Candida infection
| 142.6 (72) | 68 to 201 | 0.0001 | Subjects without Candida infection
| 412.3 (93) | 189 to 516 | |
| | | Mean (standard deviation) | 95% confidence interval | value |
| Mean CD4 counts in relation to WHO clinical stage (cells/µL) | Stage I
| 407.8 (114) | 312 to 502 | 0.0001 | Stage II
| 308.2 (98) | 218 to 489 | 0.0001 | Stage III
| 190.7 (92) | 95 to 263 | 0.0001 | Stage IV
| 96.1 (45) | 35 to 116 | |
|
|